Global gene expression by Bacillus anthracis during growth in mammalian blood

Pathogens and Disease
Paul E CarlsonPhilip C Hanna

Abstract

During the late stages of systemic anthrax, Bacillus anthracis grows rapidly in the host bloodstream. To identify potential genes necessary for this observed rapid growth, we defined the transcriptional profile of B. anthracis during in vitro growth in bovine blood. Genome-wide transcriptome analysis indicated that B. anthracis undergoes significant changes in its transcriptome profile during growth in blood, including the differential regulation of genes associated both with metabolism and known virulence factors. Collectively, these data provide a framework for future studies identifying specific B. anthracis factors required for growth in the mammalian bloodstream.

References

Jun 1, 1974·The Journal of Applied Bacteriology·H U Kim, J M Goepfert
Jul 11, 1998·Science·P Hanna
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·G M YoungV L Miller
Sep 9, 1999·The New England Journal of Medicine·T C DixonP C Hanna
Jun 1, 1954·The British Journal of Ophthalmology·C WUNDERLY, B CAGIANUT
Dec 6, 2005·Applied Bioinformatics·Satish Patel, James Lyons-Weiler
May 2, 2007·Infection and Immunity·Nicholas H BergmanPhilip C Hanna
Jul 31, 2007·Future Microbiology·Karla D Passalacqua, Nicholas H Bergman
Feb 20, 2008·PLoS Pathogens·Shalaka SamantAlexander A Neyfakh
May 4, 2010·Journal of Bacteriology·Yael TarlovskyAnthony W Maresso
May 22, 2010·Molecular Microbiology·Paul E CarlsonPhilip C Hanna
Mar 21, 2012·Molecular Microbiology·Shandee D DixonPhilip C Hanna
May 13, 2015·Journal of Bacteriology·Austen TerwilligerAnthony Maresso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

PLoS Pathogens
Richard OkinakaPaul Keim
Nihon saikingaku zasshi. Japanese journal of bacteriology
Eiko Yabuuchi
Zhurnal mikrobiologii, epidemiologii, i immunobiologii
P I NaĭmanovIu A Akhmedzianov
© 2021 Meta ULC. All rights reserved